氧化应激在患有鼻腔呼吸功能障碍和OSASS的患者中
Desiderio Passali1, Mariaconsiglia Santantonio2, Giulio Cesare Passali3
1University of Siena ENT Clinic, Former IFOS President, Siena, Italy.
Sleep & breathing = Schlaf & Atmung
|May 19, 2025
概括
在患有阻塞性睡眠呼吸暂停 (OSAS) 和鼻腔阻塞的患者中,评估了氧化应激标志物. 两组之间没有发现生物标志物的显著差异,这表明鼻腔空气流量限制可能导致睡眠呼吸障碍.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 生物化学 生物化学
- 睡眠科学 睡眠科学
背景情况:
- 研究了氧化应激生物标志物在阻断性睡眠呼吸暂停综合征 (OSAS) 的临床意义.
- 检查了鼻腔呼吸道阻塞对OSAS患者氧化平衡的影响.
研究的目的:
- 评估不同程度的OSAS和鼻腔阻塞患者的氧化应激生物标志物.
- 了解睡眠呼吸障碍中鼻腔空气流量限制和氧化应激之间的关系.
主要方法:
- 60名患者被分为严重的OSAS (AHI>30),轻微的OSAS (打,AHI <15) 和鼻子功能障碍 (AHI <5) 组.
- 所有参与者都接受了耳鼻腔检查,鼻腔测量,多睡眠学和氧化应激生物标志物分析.
- 测量的关键生物标志物包括NPBI,AOPP,异醇和醇.
主要成果:
- 在这三组患者中,氧化应激生物标志物 (NPBI,AOPP,伊索普罗斯坦,醇) 的统计学上没有显著差异.
- 这表明,常见的氧化应激标志物可能无法区分OSAS严重程度或孤立的鼻腔阻塞.
结论:
- 鼻腔阻塞患者的氧化应激标志物,即使没有严重的OSAS,也表明鼻腔空气流量限制在睡眠呼吸障碍的发病过程中的作用.
- 了解氧化压力概况可以完善睡眠呼吸障碍的诊断和治疗方法,可能减少对多睡眠监测的依赖.
更多相关视频
相关概念视频
Sleep Apnea
120
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
120
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Respiratory Assessment: Purpose and Indications
1000
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1000
Acute Respiratory Failure-IV
115
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
115
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
148
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
148
Acute Respiratory Failure-II
157
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
157


